EQ-5D-3L和FACT量表对北京癌症及癌前病变患者生活质量评估的信度和效度研究
本文选题:肿瘤 + 欧洲五维健康量表 ; 参考:《肿瘤》2017年09期
【摘要】:目的:本研究依托2013—2014年在北京市城市地区开展的食管癌、胃癌、结直肠癌、肝癌、肺癌和乳腺癌的人群筛查和早诊早治现场,采用欧洲五维健康量表EQ-5D-3L和癌症治疗功能评价量表(Functional Assessment of Cancer Therapy,FACT)对癌症及癌前病变患者的健康相关生活质量进行测量,并分析EQ-5D-3L和FACT针对北京市癌症人群的信度及效度。方法:采用EQ-5D-3L和FACT同时对1 001例癌症及癌前病变患者进行测量,对EQ-5D-3L及FACT的结果进行Cronbachα系数的内部一致性信度检验,对FACT采用公因子进行结构效度分析,对EQ-5D-3L和FACT进行对比以实现聚合效度的分析。结果 :对于肺癌、乳腺癌、结直肠癌、食管癌、肝癌和胃癌这6种癌症,EQ-5D-3L的Cronbachα系数分别为0.846、0.805、0.877、0.862、0.793和0.844,FACT的Cronbachα系数分别为0.935、0.916、0.950、0.952、0.915和0.953。在结构效度分析中,FACT累积解释方差分别为64.28%、65.15%、71.43%、67.21%、64.76%和70.56%。对比FACT,EQ-5D-3L的聚合效度分别为0.592、0.503、0.715、0.672、0.561和0.444,EQ-视觉模拟量表的聚合效度分别为0.553、0.606、0.576、0.579、0.361和0.364。结论 :EQ-5D-3L和FACT应用于北京市癌症及癌前病变患者的生活质量评估,具有较好的信度。FACT 6种癌症量表的结构效度较好,肺癌、乳腺癌、结直肠癌、肝癌和食管癌的EQ-5D-3L量表效度也较好,而胃癌及癌前病变的EQ-5D-3L量表效度一般。
[Abstract]:Objective: this study was based on screening and early diagnosis and treatment of esophageal cancer, gastric cancer, colorectal cancer, liver cancer, lung cancer and breast cancer in urban areas of Beijing from 2013 to 2014. EQ-5D-3L and functional Assessment of Cancer Therapeutics were used to measure the health-related quality of life in patients with cancer and precancerous lesions. The reliability and validity of EQ-5D-3L and fact for cancer patients in Beijing were analyzed. Methods: 1 001 patients with cancer and precancerous lesions were measured by EQ-5D-3L and fact. The results of EQ-5D-3L and fact were tested for the internal consistency reliability of Cronbach 伪 coefficients, and the structural validity of the common factors were analyzed. EQ-5 D-3 L and fact were compared to achieve the analysis of polymerization validity. Results: for lung cancer, breast cancer, colorectal cancer, esophageal cancer, liver cancer and gastric cancer, the Cronbach 伪 coefficients of EQ-5D-3L were 0.846 ~ 0.805 ~ (0.877) ~ 0.862 ~ 0.793 and 0.84 ~ (4) FACT, respectively. The Cronbach 伪 coefficients of six kinds of cancer were 0.9350.9160.9500.9520.915 and 0.95353 respectively. In the structural validity analysis, the variance of the cumulative interpretation of facts was 64.285.15 and 71.437.21, 64.76% and 70.5656%, respectively. Compared with facts EQ-5D-3L, the polymerization validity of the EQ-5D-3L was 0.592X 0.503U 0.7150.672U 0.561 and 0.444EQ- visual analogue scale 0.5530.6060.5760.5790.361 and 0.364 respectively. Conclusion the quality of life of patients with cancer and precancerous lesions in Beijing was evaluated by using the weight EQ-5D-3L and fact. The reliability of the six cancer scales was good. The structural validity of the six cancer scales was good, lung cancer, breast cancer, colorectal cancer, lung cancer, breast cancer and colorectal cancer. The validity of EQ-5D-3L scale for liver cancer and esophageal carcinoma was also good, while the validity of EQ-5D-3L scale for gastric cancer and precancerous lesions was moderate.
【作者单位】: 中国医学科学院医学信息研究所公共卫生信息研究室;
【分类号】:R73-31
【相似文献】
相关期刊论文 前10条
1 周立君;孙韬;陈德娇;;胃癌前病变患者胃内理化因素的分析[J];山东医药;2008年34期
2 周立君;孙韬;陈德娇;;胃癌前病变患者胃内理化因素的研究[J];中国煤炭工业医学杂志;2006年03期
3 周立君;孙韬;陈德娇;;胃癌前病变患者胃内理化因素的研究[J];中国实用内科杂志;2007年S2期
4 温玲;付建国;王洪庆;;宫颈癌及宫颈癌前病变患者抑郁原因及其影响因素[J];山东医药;2009年41期
5 李隆玉;乔志强;张燕玲;吴云燕;;宫颈癌前病变患者年龄结构的临床观察[J];肿瘤防治杂志;2005年24期
6 孙静华;陈玉;李仪红;樊明文;侯本祥;孔璐;;胃癌前病变患者口腔细菌多样性分析[J];北京口腔医学;2014年02期
7 谢晶日;王美蓉;李明;;胃灵颗粒对胃癌前病变患者血清生长激素影响的研究[J];中华中医药学刊;2011年02期
8 岳文彬;郭涛;范宗民;王立东;;食管癌及癌前病变患者血清中多个自身抗体检测的研究[J];河南医学研究;2010年02期
9 黄桂玲;钱捷;王少康;苏明;印虹;孙桂菊;;应用蛋白质芯片检测食管癌及癌前病变患者血清中的自身抗体[J];肿瘤;2013年12期
10 郭霞;郝轶;吐尔逊帕夏·吾布力卡斯木;哈丽丹·热依木;纳菲沙·卡德尔;武贵臻;阿布力孜·阿布杜拉;;基于蛋白质组学技术筛查维吾尔族妇女宫颈癌前病变患者血浆蛋白预警标志物[J];科技导报;2012年09期
相关会议论文 前2条
1 梁国英;;欣胃颗粒治疗胃癌前病变患者临床观察[A];第二十五届全国中西医结合消化系统疾病学术会议论文集[C];2013年
2 梁静;卞美璐;刘霞;欧华;李敏;刘军;;宫颈癌及癌前病变患者中细胞周期素G1表达及HPV感染的研究[A];中华医学会第九次全国妇科肿瘤学术会议论文汇编[C];2006年
相关重要报纸文章 前1条
1 瑚世波邋朱荣纬;子宫癌早诊早治项目在镇安实施[N];商洛日报;2008年
相关博士学位论文 前1条
1 杜芳;食管癌和贲门癌及癌前病变患者血清多种自身抗体微阵列检测[D];郑州大学;2006年
,本文编号:2087797
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2087797.html